I conducted market research and helped to create marketing copy used on the web, in emails, and in print. The material revolved around CUTANA, a new class of products that utilize a novel method for chromatin and epigenetic research. I also found and helped implement a new company-wide project management tool. Click below to see the final presentation.

The Triangle Health Innovation Challenge (THInC) is a 3-day hackathon focused on innovating healthcare solutions. In 48 hours, you pitch an idea, form a team and develop a business model surrounding your solution to an unmet need in the healthcare industry. My team and I made it to the final judging round with our pitch, NewMoms, a daily mood tracking app to identify the signs of postpartum depression before they become severe. Click the image below to see the pitch presentation. Click here to see a video of the conference. 

Novozymes is a global industrial enzyme producer.  Semester-long team identified market trends surrounding the US fats and oils markets. The goal was to identify potential drivers for a reported increase in sales for a platform technology. Click on the image below to view the final presentation.

NC State's Office of Research Commercialization assigned the team a PI to help bring their product to fruition. Our project focused on a fish feed alternative. Click below to see the final presentation.

KBI Biopharma is a contract development and manufacturing company that strives to produce high-quality biomanufactured products in a timely fashion to their clients. This involves optimizing processing procedures to improve efficiency and stay up-to-date on available technology.  The team's semester-long focused on assessing KBI's downstream buffer preparation process through the lens of equipment suggestions. We performed a voice of customer campaign to understand what other leaders were doing in buffer prep and surveyed the market for novel buffer prep mixers . Click below to see the final presentation.

Only 5% of municipal solid waste (MSW) is composted though it is estimated that up to 50% is organic, compostable material. The Food and Agriculture Organization (FAO) of the United Nations estimates that food waste alone makes up 1.3 billion tons of MSW. When organic matter or bio-waste decomposes in landfills deleterious greenhouse gases (GHG) are released into the environment. Findings from major global studies from organizations, like the FAO, have fueled a grassroots movement of at-home composting and created political pressure for sustainable waste management practices, like composting organic waste. This review provides a summary of methods that leverage nature's decomposers for municipal bio-waste management at the residential and industrial levels and their environmental impact. Click below to read the paper.

A cornerstone of the FDA is to ensure that commercial foods are safe for consumption. However, professionals argue that the current framework has significant flaws that allow substances to avoid regulation. In my term paper, I took a deep dive into the history of food regulation and the law around foods that are "generally regarded as safe(GRAS)". I also addressed the controversial ruling that genetically modified foods would be GRAS and therefore exempt from approval. Click below to see the final presentation. Click here to read the entire paper.

Driven by the scientific community, the U.S. Food and Drug Administration (FDA) began reviewing reports on trans fats which ultimately led to a change in public policy. This review aims to chronologize the regulations passed regarding PHOs, note relevant market changes reported during these regulation changes, and identify existing alternatives and novel alternatives that food and oil producers currently have. To read full literature review, click below.

Phenylketonuria (PKU) is averaged to occur 1 in every 15,000 newborns in the United States. PKU is an autosomal recessive disorder that is characterized by the inability to metabolize phenylalanine(Phe) due to a deficiency in the enzyme phenylalanine hydroxylase (PAH) found in the liver. When not properly managed, the accumulation of Phe is toxic to the nervous system and can result in irreversible intellectual disability. Newborn screening is possible with a blood test that can be given to newborns a couple of days after birth to detect high levels of PKU.  However, with no cure, strict dietary management is the main treatment available for PKU patients. To read about the solutions for PKU, click below. 

LCMS Limited is a local start-up that offers LC/MS training services as well as method development and sample analysis. Below is the final presentation of our month-long, deep-dive into the market feasibility of their proposed kit. 

Optimized Trial Screening is a start-up in the very beginning stages focused on improving the patient recruitment process for clinical trials. Below is the culmination of our team's semester-long assessment of the market space including voice of customer and competitive analysis. Click below to see the final presentation.

The team worked with microneedle specialist, Michael Daniele, Ph.D. to better understand where his platform technology could fit into the market. To identify areas with unmet needs we conducted a competitive literature and commercial product analysis. Click below to see the final presentation.

I worked with two other MBA students to help a small North Carolina flooring company with their marketing efforts. We first identified the different markets they services and assessed their opportunity level. Then we developed brand guidelines and other marketing collateral templates for future use. Click the image below to see the final presentation.

Though it will take decades of data gathering to shift healthcare away from treating based on “signs and symptoms” to treatments based on disease predispositions, there have already been some therapies (gene, cell, or biomarker-based) come through the clinical pipeline in the almost two decades since the Human Genome Project was completed. The actualization of these therapies has brought about issues ranging from commercialization and payment issues to ethical and public perception concerns. In an effort to narrow the breadth of precision medicine, this review focuses on a market overview of gene therapies and assesses the challenges that have come about while attempting to deliver these groundbreaking therapies to the public. Click below to see the final presentation. Click here to read the entire paper.